Medical Research Council (MRC) / Uganda Virus Research Institute (UVRI) Masaka Field Station Trials

Medical Research Council (MRC) / Uganda Virus Research Institute (UVRI) Masaka Field Station	Welcome, Profile Billing Logout

Medical Research Council (MRC) / Uganda Virus Research Institute (UVRI) Masaka Field Station

Welcome, Profile Billing Logout

1 Trial

2 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Kibengo, Freddie

ALTER, NCT04021121: Adjunctive Linezolid for the Treatment of Tuberculous Meningitis

Completed

RoW

LZD, Linezolid, High dose RIF, Standard dose RIF

University of California, San Francisco, MRC/UVRI and LSHTM Uganda Research Unit, London School of Hygiene and Tropical Medicine, Fogarty International Center of the National Institute of Health

Tuberculosis, Meningeal

07/23

12/23

KILGORIS, NCT05372510: Feasibility of Identifying, Enrolling and Following Acute and Early HIV-1 Infected Individuals.

Recruiting

N/A

100

RoW

MRC/UVRI and LSHTM Uganda Research Unit, International AIDS Vaccine Initiative

Acute Human Immunodeficiency Virus Type I Infection

12/22

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites